Pfizer rides Paxlovid sales growth to better-than-expected third quarter By Tom Murphy - Associated Press Shares
Switch from selling COVID-19 drugs on market rather than to governments continues to sting at Pfizer By Tom Murphy - Associated Press Shares
Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous By Tom Murphy - Associated Press Shares
Pfizer trims expectations for 2023 with sales of COVID-19 vaccine, treatment, weaker than thought By Michelle Chapman - Associated Press Shares
Pfizer buys Seagen for $43B, boosts access to cancer drugs By Tom Murphy and Michelle Chapman - Associated Press Shares
Pfizer buying spree continues with $5.4B hematology deal By Tom Murphy and Michelle Chapman - Associated Press Shares
Japan prepares for 3rd virus emergency in Tokyo, Osaka areas By MARI YAMAGUCHI - Associated Press Shares
Japanese leader asks Pfizer for additional vaccine supply By MARI YAMAGUCHI - Associated Press Shares
S. Korea spy agency: N. Korea hackers targeted vaccine tech By HYUNG-JIN KIM and KIM TONG-HYUNG - Associated Press Shares
EXPLAINER: Japan begins vaccination drive, but why so late? By MARI YAMAGUCHI - Associated Press Shares
Insider Q&A: Pfizer exec talks ramping up vaccine supply By LINDA A. JOHNSON - Associated Press Shares
